Topical NSAIDs are better than placebo. Safety, efficacy, and therapeutic role of nsaids must be clarified.
作者信息
Duerden M, Barton S, Johnstone E, MacLean K, Underhill J, Walley T
出版信息
BMJ. 1998 Jul 25;317(7153):280-1; author reply 281. doi: 10.1136/bmj.317.7153.280a.
Abstract
摘要
相似文献
1
Topical NSAIDs are better than placebo. Safety, efficacy, and therapeutic role of nsaids must be clarified.局部用非甾体抗炎药优于安慰剂。非甾体抗炎药的安全性、有效性及治疗作用必须予以阐明。
BMJ. 1998 Jul 25;317(7153):280-1; author reply 281. doi: 10.1136/bmj.317.7153.280a.
2
Topical NSAID therapy for musculoskeletal pain.局部用 NSAID 治疗肌肉骨骼疼痛。
Pain Med. 2010 Apr;11(4):535-49. doi: 10.1111/j.1526-4637.2010.00809.x. Epub 2010 Mar 4.
3
NSAIDs: topicals vs. pills for pain. Topicals aren't as popular, but they can be very effective.非甾体抗炎药：局部用药与口服片剂治疗疼痛。局部用药不太常用，但可能非常有效。
Harv Health Lett. 2013 Jan;38(3):4.
4
Topical NSAIDs significantly reduces pain in adults with acute musculoskeletal injuries.局部用非甾体抗炎药可显著减轻急性肌肉骨骼损伤成人的疼痛。
Evid Based Med. 2016 Oct;21(5):187-8. doi: 10.1136/ebmed-2016-110406. Epub 2016 Aug 12.
5
Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions.局部双氯芬酸的安全性概况：肌肉骨骼疾病中双盲、随机、对照试验的荟萃分析。
Curr Med Res Opin. 2011 Mar;27(3):605-22. doi: 10.1185/03007995.2010.550606. Epub 2011 Jan 13.
6
A burning concern.一个亟待解决的问题。
Johns Hopkins Med Lett Health After 50. 2012 Dec;24(11):8.
7
Topical non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of inflammatory musculoskeletal disorders.
Prostaglandins Leukot Essent Fatty Acids. 1991 Aug;43(4):209-22. doi: 10.1016/0952-3278(91)90033-2.
8
Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.
Clin Evid. 2005 Dec(14):1498-505.
9
Non-steroidal anti-inflammatory drugs.非甾体抗炎药。
Clin Evid. 2002 Dec(8):1203-11.
10
Topical nonsteroidal anti-inflammatory drugs for chronic musculoskeletal pain in adults.用于成人慢性肌肉骨骼疼痛的外用非甾体抗炎药。
Clin J Oncol Nurs. 2013 Aug 1;17(4):447-8. doi: 10.1188/13.CJON.447-448.
引用本文的文献
1
Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data.酮洛芬的光敏性：作用机制与药物流行病学数据
Drug Saf. 2000 May;22(5):339-49. doi: 10.2165/00002018-200022050-00002.
本文引用的文献
1
Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs.局部应用非甾体抗炎药的定量系统评价
BMJ. 1998 Jan 31;316(7128):333-8. doi: 10.1136/bmj.316.7128.333.
2
Placebo mania. Placebos are essential when extent and variability of placebo response are unknown.安慰剂狂热。当安慰剂反应的程度和变异性未知时，安慰剂至关重要。
BMJ. 1996 Oct 19;313(7063):1008. doi: 10.1136/bmj.313.7063.1008a.
3
Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.196项类风湿性关节炎非甾体抗炎药双盲试验报告中的方法学以及显性和隐性偏差。
Control Clin Trials. 1989 Mar;10(1):31-56. doi: 10.1016/0197-2456(89)90017-2.
Zotero 插件